drugset / Trial / NCT07056439
Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients
NaSingle-groupOpen-labelDiagnostic
Summary
This study aims to evaluate the safety and pharmacokinetics of HRS-1738 injection in adult patients with prostate cancer.
Timeline
- Start
- 2025-07
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-1738 | Unknown | — | — |
Indications
No indication recorded.